| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |